Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein AC Walls, YJ Park, MA Tortorici, A Wall, AT McGuire, D Veesler Cell 181 (2), 281-292. e6, 2020 | 10309 | 2020 |
Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding TN Starr, AJ Greaney, SK Hilton, D Ellis, KHD Crawford, AS Dingens, ... cell 182 (5), 1295-1310. e20, 2020 | 1926 | 2020 |
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody D Pinto, YJ Park, M Beltramello, AC Walls, MA Tortorici, S Bianchi, ... Nature 583 (7815), 290-295, 2020 | 1819 | 2020 |
Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology L Piccoli, YJ Park, MA Tortorici, N Czudnochowski, AC Walls, ... Cell 183 (4), 1024-1042. e21, 2020 | 1350 | 2020 |
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift E Cameroni, JE Bowen, LE Rosen, C Saliba, SK Zepeda, K Culap, ... Nature 602 (7898), 664-670, 2022 | 1153 | 2022 |
Structural insights into coronavirus entry MA Tortorici, D Veesler Advances in virus research 105, 93-116, 2019 | 921 | 2019 |
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity B Meng, A Abdullahi, IATM Ferreira, N Goonawardane, A Saito, I Kimura, ... Nature 603 (7902), 706-714, 2022 | 891 | 2022 |
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 M McCallum, A De Marco, FA Lempp, MA Tortorici, D Pinto, AC Walls, ... Cell 184 (9), 2332-2347. e16, 2021 | 878 | 2021 |
Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays KHD Crawford, R Eguia, AS Dingens, AN Loes, KD Malone, CR Wolf, ... Viruses 12 (5), 513, 2020 | 747 | 2020 |
Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ... Nature 593 (7857), 136-141, 2021 | 705 | 2021 |
Unexpected receptor functional mimicry elucidates activation of coronavirus fusion AC Walls, X Xiong, YJ Park, MA Tortorici, J Snijder, J Quispe, E Cameroni, ... Cell 176 (5), 1026-1039. e15, 2019 | 624 | 2019 |
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors L Cao, I Goreshnik, B Coventry, JB Case, L Miller, L Kozodoy, RE Chen, ... Science 370 (6515), 426-431, 2020 | 615 | 2020 |
Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion AC Walls, MA Tortorici, J Snijder, X Xiong, BJ Bosch, FA Rey, D Veesler Proceedings of the National Academy of Sciences 114 (42), 11157-11162, 2017 | 606 | 2017 |
Structural basis for human coronavirus attachment to sialic acid receptors MA Tortorici, AC Walls, Y Lang, C Wang, Z Li, D Koerhuis, GJ Boons, ... Nature structural & molecular biology 26 (6), 481-489, 2019 | 605 | 2019 |
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 EB Hodcroft, M Zuber, S Nadeau, TG Vaughan, KHD Crawford, ... Nature 595 (7869), 707-712, 2021 | 593 | 2021 |
Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer AC Walls, MA Tortorici, BJ Bosch, B Frenz, PJM Rottier, F DiMaio, FA Rey, ... Nature 531 (7592), 114-117, 2016 | 552 | 2016 |
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms MA Tortorici, M Beltramello, FA Lempp, D Pinto, HV Dang, LE Rosen, ... Science 370 (6519), 950-957, 2020 | 525 | 2020 |
SARS-CoV-2 immune evasion by the B. 1.427/B. 1.429 variant of concern M McCallum, J Bassi, A De Marco, A Chen, AC Walls, J Di Iulio, ... Science 373 (6555), 648-654, 2021 | 512 | 2021 |
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2 AC Walls, B Fiala, A Schäfer, S Wrenn, MN Pham, M Murphy, ... Cell 183 (5), 1367-1382. e17, 2020 | 472 | 2020 |
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement M McCallum, N Czudnochowski, LE Rosen, SK Zepeda, JE Bowen, ... Science 375 (6583), 864-868, 2022 | 466 | 2022 |